Imvaria, Inc.

Imvaria, Inc. has 3 AI-enabled medical devices on the FDA list. The first decision was on January 12, 2024 and the most recent on November 7, 2025 (Fibresolve (with PCCP)). Its most common review panel is Radiology (3 devices).